Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $136.76 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $100.01 | 7 | $0 (2020) |
| Eisai Inc. | $21.24 | 1 | $0 (2017) |
| Lilly USA, LLC | $15.51 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $15.51 | 1 | Lilly USA, LLC ($15.51) |
| 2020 | $15.19 | 1 | Novo Nordisk Inc ($15.19) |
| 2018 | $69.57 | 5 | Novo Nordisk Inc ($69.57) |
| 2017 | $36.49 | 2 | Eisai Inc. ($21.24) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/09/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Neuroscience | ||||||
| 07/10/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Diabetes | ||||||
| 11/07/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Diabetes | ||||||
| 05/31/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $10.98 | General |
| Category: Diabetes | ||||||
| 05/16/2018 | Novo Nordisk Inc | Xultophy 100/3.6 (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: Diabetes | ||||||
| 03/28/2018 | Novo Nordisk Inc | Xultophy 100/3.6 (Drug) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: Diabetes | ||||||
| 02/28/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Diabetes | ||||||
| 11/13/2017 | Novo Nordisk Inc | Xultophy 100/3.6 (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Diabetes | ||||||
| 09/21/2017 | Eisai Inc. | Belviq (Drug) | Food and Beverage | Cash or cash equivalent | $21.24 | General |
| Category: Nutrition and Weight Loss | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 33 | 34 | $8,444 | $1,453 |
| 2022 | 21 | 942 | 972 | $149,211 | $44,838 |
| 2021 | 21 | 787 | 810 | $91,008 | $33,442 |
| 2020 | 16 | 640 | 666 | $83,067 | $23,439 |
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 22 | 23 | $7,064 | $900.19 | 12.7% |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | Office | 2023 | 11 | 11 | $1,381 | $553.08 | 40.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 218 | 233 | $70,404 | $19,637 | 27.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 92 | 97 | $20,698 | $6,157 | 29.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 39 | 39 | $16,359 | $4,395 | 26.9% |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | Office | 2022 | 55 | 57 | $7,154 | $2,833 | 39.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $8,308 | $2,185 | 26.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 25 | 25 | $7,219 | $1,825 | 25.3% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2022 | 17 | 17 | $3,421 | $1,604 | 46.9% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 22 | 22 | $3,234 | $1,439 | 44.5% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 52 | 52 | $4,754 | $1,262 | 26.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 22 | 22 | $1,392 | $657.80 | 47.3% |
| 0134A | Fee covid-19 vac 14 res | Office | 2022 | 14 | 14 | $560.00 | $474.84 | 84.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 42 | 43 | $956.75 | $448.64 | 46.9% |
| 87086 | Bacterial colony count, urine | Office | 2022 | 47 | 47 | $857.75 | $374.57 | 43.7% |
| 84484 | Troponin (protein) analysis, quantitative | Office | 2022 | 25 | 25 | $656.25 | $307.55 | 46.9% |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | Office | 2022 | 33 | 34 | $663.00 | $290.39 | 43.8% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2022 | 34 | 35 | $507.50 | $223.93 | 44.1% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2022 | 62 | 62 | $449.50 | $194.32 | 43.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 58 | 62 | $449.50 | $183.60 | 40.8% |
| 87088 | Bacterial urine culture | Office | 2022 | 22 | 22 | $379.50 | $175.74 | 46.3% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2022 | 28 | 28 | $701.25 | $131.53 | 18.8% |
| 81003 | Automated urinalysis test | Office | 2022 | 16 | 17 | $89.25 | $37.65 | 42.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 120 | 125 | $35,344 | $10,280 | 29.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 98 | 102 | $19,967 | $5,835 | 29.2% |
About Dr. Robert Anderson, DO
Dr. Robert Anderson, DO is a Sports Medicine healthcare provider based in Medford, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1578556155.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Anderson, DO has received a total of $136.76 in payments from pharmaceutical and medical device companies, with $15.51 received in 2021. These payments were reported across 9 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($136.76).
As a Medicare-enrolled provider, Anderson has provided services to 2,402 Medicare beneficiaries, totaling 2,482 services with total Medicare billing of $103,172. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Practice Information
- Specialty Sports Medicine
- Other Specialties Family Medicine, Family Medicine
- Location Medford, OR
- Active Since 08/29/2005
- Last Updated 09/09/2024
- Taxonomy Code 207QS0010X
- Entity Type Individual
- NPI Number 1578556155
Products in Payments
- Tresiba (Drug) $44.79
- Xultophy 100/3.6 (Drug) $40.03
- Belviq (Drug) $21.24
- EMGALITY (Drug) $15.51
- Ozempic (Drug) $15.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Sports Medicine Doctors in Medford
Steven Chamberlain, Md, MD
Sports Medicine — Payments: $196.01
Richard James, Md, MD
Sports Medicine — Payments: $98.79
Thomas Schumann
Sports Medicine — Payments: $98.34
David Galt, Md, MD
Sports Medicine — Payments: $29.20
Charles Versteeg, Md, MD
Sports Medicine
Michael Potter, M.d, M.D
Sports Medicine